Prescription drug · NDA
Lovenox (Enoxaparin sodium) NDC 55154-4028
Enoxaparin sodium 40 mg/.4mL · Injection · Subcutaneous · Cardinal Health 107, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55154-4028-5 | 5515440280555154402805 | 5 SYRINGE in 1 BAG (55154-4028-5) / .4 mL in 1 SYRINGEMarketed from Mar 29, 1993 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lovenox
- Generic name (nonproprietary)
- enoxaparin sodium
- Active ingredients
- Enoxaparin sodium — 40 mg/.4mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Labeler
- Cardinal Health 107, LLCNDC labeler code 55154
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020164
- Marketing start
- Listing expires
- Other FDA classes
- Low-Molecular-Weight (Chemical structure)
- Identifiers
- Product ID 55154-4028_ebd70650-9a1a-4922-859c-d14448c43c70SPL ID ebd70650-9a1a-4922-859c-d14448c43c70SPL set ID 3d263380-4f44-4fd8-aa2a-e69702ab258fRxCUI 854235, 854236UNII 8NZ41MIK1OUPC 0055154402859
- Pharmacologic class
- Low Molecular Weight Heparin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455154402805followed by a unit qualifier and the quantityPackage 55154-4028-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lovenox is a low molecular weight heparin (LMWH) indicated for: • Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1 ) • Inpatient treatment of acute DVT with or without pulmonary embolism ( 1.2 ) • Outpatient treatment of acute DVT without pulmonary embolism ( 1.2 ) • Prophylaxis of ischemic complications of unstable angina and non–Q-wave myocardial infarction (MI) ( 1.3 ) • Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI) ( 1.4 ) 1.1 Prophylaxis of D…
Excerpt only. Read the full label for complete information.
About NDC 55154-4028
- What is NDC 55154-4028?
- 55154-4028 is the product NDC for Lovenox (enoxaparin sodium), Enoxaparin sodium 40 mg/.4mL injection, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lovenox (Enoxaparin sodium).
- What is the active ingredient?
- Enoxaparin sodium.
- Who is the labeler?
- Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lovenox?
- 16 other product NDCs are listed under this name. See all Lovenox NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lovenox products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lovenoxenoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0620 | 00075-0620-40 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0621 | 00075-0621-60 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0622 | 00075-0622-80 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0623 | 00075-0623-00 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0624 | 00075-0624-30 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0075-0626 | 00075-0626-03 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-2912 | 00075-2912-01 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-2915 | 00075-2915-01 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8013 | 00075-8013-10 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8014 | 00075-8014-10 |
Other NDCs under NDA 020164
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Enoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1010 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-0620 |
| Enoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1004 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-2915 |
| Enoxaparin sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1006 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8025 |
| Enoxaparin sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1008 |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-531 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0075-0626 |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-531 |
| Enoxaparin sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0955-1012 |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-535 |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-533 |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-533 |
| Lovenoxenoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Sanofi-Aventis U.S. LLC | 0075-8020 |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-539 |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-535 |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-537 |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-537 |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-539 |
Showing 20 of 39.